Log in

ETR:MOR - MorphoSys Stock Price, Forecast & News

€120.40
+1.50 (+1.26 %)
(As of 12/9/2019 08:26 AM ET)
Today's Range
€118.30
Now: €120.40
€121.50
50-Day Range
€94.65
MA: €102.88
€118.90
52-Week Range
€79.70
Now: €120.40
€118.90
Volume80,230 shs
Average Volume153,687 shs
Market Capitalization$3.81 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MorphoSys AG, together with its subsidiaries, develops and commercializes antibodies and peptides for therapeutic applications in the United States. The company, together with its pharmaceutical partners, develops a therapeutic pipeline of approximately 115 drugs for various diseases, such as psoriasis, Alzheimer's diseases, haematological malignancies, solid tumors, hemophilia, multiple myeloma, metabolic diseases, inflamation, thrombosis, brittle bone syndrome, eye diseases, cancers, diabetic eye diseases, blood disorders, and asthma. Read More…

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-89-899270

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$71.16 million
Cash Flow€12.39 per share
Book Value€13.99 per share

Profitability

Miscellaneous

Employees329
Market Cap$3.81 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive MOR News and Ratings via Email

Sign-up to receive the latest news and ratings for MOR and its competitors with MarketBeat's FREE daily newsletter.


MorphoSys (ETR:MOR) Frequently Asked Questions

What is MorphoSys' stock symbol?

MorphoSys trades on the ETR under the ticker symbol "MOR."

What price target have analysts set for MOR?

7 Wall Street analysts have issued 1 year target prices for MorphoSys' stock. Their forecasts range from €81.00 to €145.00. On average, they expect MorphoSys' share price to reach €119.86 in the next twelve months. This suggests that the stock has a possible downside of 0.5%. View Analyst Price Targets for MorphoSys.

What is the consensus analysts' recommendation for MorphoSys?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MorphoSys in the last year. There are currently 1 sell rating, 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MorphoSys.

Has MorphoSys been receiving favorable news coverage?

News articles about MOR stock have been trending somewhat negative on Monday, InfoTrie Sentiment reports. The research group identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. MorphoSys earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the next few days. View News Stories for MorphoSys.

Who are some of MorphoSys' key competitors?

What other stocks do shareholders of MorphoSys own?

Who are MorphoSys' key executives?

MorphoSys' management team includes the folowing people:
  • Dr. Simon E. Moroney, Chairman of Management Board & CEO (Age 59)
  • Mr. Jens H. Holstein, CFO & Member of Management Board (Age 55)
  • Dr. Markus Enzelberger, Chief Scientific Officer & Member of Management Board (Age 49)
  • Dr. Malte Peters, Chief Devel. Officer & Member of Management Board (Age 57)
  • Mr. Klaus De Wall, Head of Accounting & Tax

What is MorphoSys' stock price today?

One share of MOR stock can currently be purchased for approximately €120.40.

How big of a company is MorphoSys?

MorphoSys has a market capitalization of $3.81 billion and generates $71.16 million in revenue each year. MorphoSys employs 329 workers across the globe.View Additional Information About MorphoSys.

What is MorphoSys' official website?

The official website for MorphoSys is http://www.morphosys.de/.

How can I contact MorphoSys?

MorphoSys' mailing address is Semmelweisstr. 7, PLANEGG, 82152, Germany. The company can be reached via phone at +49-89-899270.


MarketBeat Community Rating for MorphoSys (ETR MOR)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  275 (Vote Outperform)
Underperform Votes:  217 (Vote Underperform)
Total Votes:  492
MarketBeat's community ratings are surveys of what our community members think about MorphoSys and other stocks. Vote "Outperform" if you believe MOR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MOR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/9/2019 by MarketBeat.com Staff

Featured Article: What is the QQQ ETF?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel